Literature DB >> 11929553

Oral yeast carriage in patients with advanced cancer.

A N Davies1, S Brailsford, K Broadley, D Beighton.   

Abstract

The aim of this study was to investigate oral yeast carriage amongst patients with advanced cancer. Oral rinse samples were obtained from 120 subjects. Yeasts were isolated using Sabouraud's dextrose agar and CHROMagar Candida, and were identified using a combination of the API 20 C AUX yeast identification system, species-specific PCR and 26S rDNA gene sequencing. Oral yeast carriage was present in 66% of subjects. The frequency of isolation of individual species was: Candida albicans, 46%; Candida glabrata, 18%; Candida dubliniensis, 5%; others, < 5%. The increasing isolation of non-Candida albicans species is clinically important, since these species are often more resistant to antifungal drugs. Oral yeast carriage was associated with denture wearing (P = 0.006), and low stimulated whole salivary flow rate (P = 0.009). Identification of these risk factors offers new strategies for the prevention of oral candidosis in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929553     DOI: 10.1046/j.0902-0055.2001.00095.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  16 in total

1.  Relative Abundances of Candida albicans and Candida glabrata in In Vitro Coculture Biofilms Impact Biofilm Structure and Formation.

Authors:  Michelle L Olson; Arul Jayaraman; Katy C Kao
Journal:  Appl Environ Microbiol       Date:  2018-04-02       Impact factor: 4.792

2.  Significance of oral Candida infections in children with cancer.

Authors:  Márta Alberth; László Majoros; Gabriella Kovalecz; Emese Borbás; István Szegedi; Ildikó J Márton; Csongor Kiss
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

Review 4.  Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.

Authors:  Rene-Jean Bensadoun; Lauren L Patton; Rajesh V Lalla; Joel B Epstein
Journal:  Support Care Cancer       Date:  2011-04-10       Impact factor: 3.603

5.  In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY).

Authors:  X Z Wang; B Fan; L G Liu; X Y Hu; R Y Li; Y Wei; Z Wan; X L Deng
Journal:  Mycopathologia       Date:  2008-03-14       Impact factor: 2.574

6.  Oral health conditions affect functional and social activities of terminally ill cancer patients.

Authors:  D J Fischer; J B Epstein; Y Yao; D J Wilkie
Journal:  Support Care Cancer       Date:  2014-03       Impact factor: 3.603

7.  Patients with long-term oral carriage harbor high-persister mutants of Candida albicans.

Authors:  Michael D Lafleur; Qingguo Qi; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

8.  Epithelial GM-CSF induction by Candida glabrata.

Authors:  L Li; A Dongari-Bagtzoglou
Journal:  J Dent Res       Date:  2009-08       Impact factor: 6.116

9.  Preparation, in vitro characterization and preliminary in vivo evaluation of buccal polymeric films containing chlorhexidine.

Authors:  Claudia Juliano; Massimo Cossu; Paola Pigozzi; Giovanna Rassu; Paolo Giunchedi
Journal:  AAPS PharmSciTech       Date:  2008-11-19       Impact factor: 3.246

10.  Oral Candida infection and colonization in solid organ transplant recipients.

Authors:  A Dongari-Bagtzoglou; P Dwivedi; E Ioannidou; M Shaqman; D Hull; J Burleson
Journal:  Oral Microbiol Immunol       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.